Press release
Pharmacovigilance Market Is Expected To Reach USD 21.4 Billion By 2031
Get Sample Copy With Covid19 Impact Analysis: https://www.sheeranalyticsandinsights.com/request-sample/pharmacovigilance-market-21
Increased cases of chronic diseases like diabetes, oncological diseases, cardiovascular and respiratory disorders have led to the consumption of the drug across the world. Also the increased incidences of Adverse Drug Reactions ADRs) will help to accelerate the growth of this market during the forecasted period. also, the demand for the development of new drugs via extensive clinical trials has increased. But because of the current COVID-19 pandemic, there has been an adverse effect on the market.
Geographically, The Global Pharmacovigilance Market is divided into global regions like North America, Europe, Asia- Pacific, Latin America, Middle East, and Africa.
The primary key players in the Global Pharmacovigilance Market include Accenture, Linical Accelovance, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, IQVIA, TAKE Solutions Ltd., PAREXEL International Corporation, BioClinica Inc., Wipro Ltd., United BioSource Corporation.
Browse the Full Report at https://www.sheeranalyticsandinsights.com/market-report-research/pharmacovigilance-market-21
The Global Pharmacovigilance Market Has Been Segmented Into:
By Service Provider
• In-house
• Contract Outsourcing
By Product Life Cycle
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV
By Type
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining
By Process Flow
• Case Data Management
o Case Logging
o Case Data Analysis
o Medical Reviewing & Reporting
• Signal Detection
o Adverse Event Logging
o Adverse Event Analysis
o Adverse Event Review & Reporting
• Risk Management System
o Risk Evaluation System
o Risk Mitigation System
By Therapeutic Area
• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others
By End-Use
• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers
• Others
By Geography
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Download Free PDF Sample Request: https://www.sheeranalyticsandinsights.com/request-sample/pharmacovigilance-market-21
Contact us:
Name: Abhigyan Sengupta
(Global sales Manager)
Ph.: +1-414-240-5010 (U.S.)
Email: sales@sheeranalyticsandinsights.com
Website: https://www.sheeranalyticsandinsights.com/
About Us:
Sheer Analytics and Insights as firm is created to balance between client requirements without compromising the core values of Market research in –terms of quality, factual correctness, market awareness and analysis. SAI goes back to the root of Market Research in terms of TAM (Total Available Market) and PAM (Potential Available Market) and assess the same quantifying all Push and Pull factors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacovigilance Market Is Expected To Reach USD 21.4 Billion By 2031 here
News-ID: 2235699 • Views: …
More Releases from Sheer Analytics and Insights
Oligonucleotide Synthesis Market is Expected to Reach $19.8 billion by 2032
According to a market report, published by Sheer Analytics and Insights, The global oligonucleotide synthesis market was valued at $3.4 billion in 2021 and it is expected to reach $19.8 billion at a CAGR of 17.1% between 2022 and 2032. Revenue generation in this market is expected to expand as a result of the recent success of oligonucleotide-based medications in medicine as a result of an increase in the number…
Global Hyperspectral Imaging Market is Expected to Reach US$ 732.2 million by 20 …
According to a market report, published by Sheer Analytics and Insights, The global hyperspectral imaging market was valued at $171.2 million in 2021 and it is expected to reach $732.2 million at a CAGR of 13.20% between 2022 and 2032. The human eye has only three color receptors such as green, blue, and red. Hyperspectral imaging measures the continuous spectrum of the light for each pixel of the scene with…
Hyperautomation Market is expected to grow at 21.7% CAGR between 2021-2031
According to a new market research report published by sheer analytics and insights, "The Global Hyperautomation Market was valued at $4.78 Billion in 2020. Growing at a high CAGR of more than 21.7% between 2021 and 2031, it is estimated to reach $46.4 Billion by 2031", as per the latest market research report titled Global Hyperautomation Market - Industry analysis, size, share, growth, trends and forecast, 2021 - 2031.
According to…
Systemic Scleroderma Treatment Market to Expand at 8.06% CAGR and Reach US$ 4.3 …
According to a new market research report published by sheer analytics and insights, “The Global Systemic Scleroderma Treatment Market was valued at $1.80 Billion in 2020. Growing at a high CAGR of more than 8.06% between 2021 and 2031, it is estimated to reach $4.3 Billion by 2031", as per the latest market research report titled Global Systemic Scleroderma Treatment Market - Industry analysis, size, share, growth, trends and forecast,…
More Releases for Pharmacovigilance
Top Pharmacovigilance Companies Analysis By 2031
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpenPR&utm_medium=10379
The List of Companies
• #Accentures
• Bristol-Myers Squibb Company
• Linical Accelovance
• Cognizant
• Covance Inc.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc.
• ICON plc
• Capgemini (IGATE Corporation)
Clinical…
Pharmacovigilance - Scope and Research Methodology
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Pharmacovigilance Market report covers analysis by Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event…
Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.
As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes…
Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Develop …
How Are the key drivers contributing to the expansion of the pharmacovigilance market?
The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches.…
Monitoring Medication Safety with Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications.
Download Sample PDF at: https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpnePR&utm_medium=10776
Increasing cases of adverse drug reactions…
Pharmacovigilance Market Opportunity Analysis by 2028
Pharmacovigilance Market: Introduction
According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before…
